Bing Pharma News, [Pharmabiz.com]
Feb. 20, 2016
Details: St. Jude Medical, a global medical device company and an international leader in the development of therapies for the treatment of chronic pain, announced FDA approval of company’s Axium Neurostimulator System for dorsal root ganglion (DRG) stimulation.
Feb. 19, 2016
Details: St. Jude Medical announced that its Axium neurostimulator has been approved by the FDA to help treat moderate to severe chronic intractable pain of the lower limbs in adults with complex regional pain syndrome (CRPS I and II) by stimulating the dorsal root ganglion (DRG). The DRG is an interesting target to stimulate electrically due its location and [ ] The post St. Jude Medical’s Axium DRG Stimulator Approved by FDA for Complex Regional Pain Syndrome appeared first on Medgadget . ]]> …
Bing Pharma News, Modern Healthcare [modernhealthcare.com] Feb. 17, 2016
Details: The FDA has approved a St. Jude Medical spinal device that treats chronic pain not relieved through traditional spinal cord stimulation. The St. Paul, Minn.-based devicemaker’s Axium Neurostimulator System is for use on the dorsal root ganglion, a spinal … …